Dr. Paul Edward Wise, MD

Dr. Wise practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Wise's NPI, 1619076056, was assigned on September 22, 2006. Dr. Wise graduated from Johns Hopkins University School of Medicine in 1996. Dr. Wise holds Missouri license 2012011934.

Dr. Wise's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Wise also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Wise's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Wise is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Wise to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wise practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Wise's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Wise is licensed in Missouri.

CMS data shows 248 Medicare services from Dr. Wise across 6 procedure codes in 2024, for 182 Medicare patients. Medicare paid $19,365 for them.

CMS counts 182 Medicare patients who saw Dr. Wise in 2024. The largest group is 65 to 74, with 86 patients. 70% of them have high blood pressure, and 63% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wise's median patient age at 67, with 54% women.

In 2024, Dr. Wise wrote 263 Medicare Part D claims for 149 patients. 76% of them were for generic drugs. CMS names the drug for 207 of them, across 7 drugs with 11 or more claims each, at $6,486 in total drug cost. In 2023, CMS named 261 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wise for performance year 2024, reported as part of a group. Dr. Wise accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wise as offering telehealth. CMS counts 36 procedures of colonoscopy by Dr. Wise, more than 57% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 100 papers to Dr. Wise, published from 2010 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Internship and Residency, Rectal Neoplasms and General Surgery. Dr. Wise has published most often in J Surg Educ. Dr. Wise's most frequent co-authors are Matthew G. Mutch, MD, Matthew Leon Silviera, MD and Sean Christopher Glasgow, MD.

Dmand AI links Dr. Wise to 6 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Rectal Neoplasms, Rectal Diseases and Adenomatous Polyposis Coli. Washington University School of Medicine sponsors the most, 5.

CMS Open Payments shows 83 general payments to Dr. Wise from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Olympus Corporation paid the most, $21,296.

Dr. Wise graduated from Johns Hopkins University School of Medicine in 1996.